Abstract
Maintaining homeostasis, the regulation of internal physiological parameters, is essential for health and well-being. Deviations from optimal levels, or ‘sweet spots,’ can lead to health deterioration and disease. Identifying biomarkers with sweet spots requires both change-point detection and variance effect analysis. Traditional approaches involve separate tests for change-points and heteroskedasticity, which can yield inaccurate results if model assumptions are violated. To address these challenges, we propose a unified approach: Bayesian Testing for Heteroskedasticity and Sweet Spots (BTHS). This framework integrates sampling-based parameter estimation and Bayes factor computation to enhance change-point detection, heteroskedasticity quantification, and testing in change-point regression settings, and extends previous Bayesian approaches. BTHS eliminates the need for separate analyses and provides detailed insights into both the magnitude and shape of heteroskedasticity, enabling robust identification of sweet spots without strong assumptions. We applied BTHS to blood elements from the Canadian Longitudinal Study on Aging identifying nine blood elements with significant sweet spot variance effects.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
